Mr Elijah Genetzakis
University of Sydney, Sydney (Australia)
IL-1b as a potential biomarker and therapeutic target in coronary artery disease
Event: ESC Congress 2023
Topic: Biomarkers
Session: Immune mechanisms in myocardial diseases
